Coherus Oncology, Inc.: shareholders and insiders

CHRSNASDAQHealthcare · Biological Products, (No Diagnostic Substances)

Price

$0.39

November 19, 2026Market cap $58M

What Ploutos Investor adds for Coherus Oncology

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 14 fiscal years, from 2012
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Notes on these figures

  • The share price has fallen 50% since Nov 9, 2026, when the 10-Q these figures come from was filed ($0.82 then, $0.41 on Nov 18, 2026). The figures date from before that move.10-Q
  • The interest the company pays is far more than the debt we can read would cost, so part of its borrowing is missing from the figures. We leave out the debt, net cash, enterprise value and the multiples built on them.

Insiders and their shares

Purchases and sales by officers and directors from Nov 19, 2025 to Jun 9, 2026, from their own Form 4 filings.

9 Form 4s

Bought on the market

–

nobody

Sold on the market

–

nobody

From Nov 19, 2025 to Nov 19, 2026, the days the chart shows. Change its range and the figures follow.

How the sales were made, as a share of their value

No sales in the period.

No trades under these filters.

From the Form 4s insiders file with the SEC within two business days of each trade.

Insiders and their shares

Every buy and sale by CHRS's officers and directors from 2014 up to November 18, 2025, 12 more calendar years

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 3 years.

Major holders (over 5%)

Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.

3 Holders over 5%Jul 27, 2026 Latest filing
  • Timothy G. Youngquist 2020 Irrevocable Trust
    Share of class8.30%
  • Bering Partners II, L.P. ("Bering II")with 5 more persons
    Share of class6.50%
  • BlackRock, Inc.
    Share of class5.80%
Fell to 5% or less (3)

Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.

  • Thomas A. Satterfield, Jr.4.60%Apr 29, 202613G/A
  • The Vanguard Group0.00%Mar 26, 202613G/A
  • Rubric Capital Management LP4.56%Feb 13, 202513G/A

From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.

Well-known managers

Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.

Sep 30, 2026 quarter end
  • Citadel Advisors (Griffin)
    In the quarter+570%
  • Millennium Mgmt (Englander)
    In the quarter+846%
  • Renaissance Technologies
    In the quarter+67%
  • AQR Capital
    In the quarter-84%

From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).

Short interest

How many of the company's shares have been sold borrowed and not yet bought back, twice a month.

On Oct 15, 2026, 8.31% of its shares outstanding were held short, -46.6% since the report before.

Shares held short
12.45M
8.31%
Since the report before23.34M on Sep 30, 2026
-46.6%
7.9
1.58M
More days to cover thanof 4,578 US-listed companies with enough volume
83%
Report date
Oct 15, 2026
  • Oct 31, 2023: Shares held short 19.84M
  • Nov 15, 2023: Shares held short 21.69M
  • Nov 30, 2023: Shares held short 21.46M
  • Dec 15, 2023: Shares held short 23.77M
  • Dec 29, 2023: Shares held short 24.23M
  • Jan 12, 2024: Shares held short 27.43M
  • Jan 31, 2024: Shares held short 28.13M
  • Feb 15, 2024: Shares held short 25.32M
  • Feb 29, 2024: Shares held short 24.20M
  • Mar 15, 2024: Shares held short 25.91M
  • Mar 28, 2024: Shares held short 23.45M
  • Apr 15, 2024: Shares held short 21.53M
  • Apr 30, 2024: Shares held short 21.69M
  • May 15, 2024: Shares held short 21.78M
  • May 31, 2024: Shares held short 22.06M
  • Jun 14, 2024: Shares held short 22.20M
  • Jun 28, 2024: Shares held short 23.04M
  • Jul 15, 2024: Shares held short 23.02M
  • Jul 31, 2024: Shares held short 22.66M
  • Aug 15, 2024: Shares held short 24.01M
  • Aug 30, 2024: Shares held short 25.15M
  • Sep 13, 2024: Shares held short 25.09M
  • Sep 30, 2024: Shares held short 27.96M
  • Oct 15, 2024: Shares held short 29.85M
  • Oct 31, 2024: Shares held short 31.51M
  • Nov 15, 2024: Shares held short 33.04M
  • Nov 29, 2024: Shares held short 30.72M
  • Dec 13, 2024: Shares held short 31.07M
  • Dec 31, 2024: Shares held short 30.72M
  • Jan 15, 2025: Shares held short 29.79M
  • Jan 31, 2025: Shares held short 30.90M
  • Feb 14, 2025: Shares held short 31.81M
  • Feb 28, 2025: Shares held short 30.77M
  • Mar 14, 2025: Shares held short 32.55M
  • Mar 31, 2025: Shares held short 32.49M
  • Apr 15, 2025: Shares held short 33.03M
  • Apr 30, 2025: Shares held short 32.57M
  • May 15, 2025: Shares held short 33.12M
  • May 30, 2025: Shares held short 32.53M
  • Jun 13, 2025: Shares held short 31.94M
  • Jun 30, 2025: Shares held short 31.94M
  • Jul 15, 2025: Shares held short 31.23M
  • Jul 31, 2025: Shares held short 32.34M
  • Aug 15, 2025: Shares held short 32.73M
  • Aug 29, 2025: Shares held short 31.93M
  • Sep 15, 2025: Shares held short 31.87M
  • Sep 30, 2025: Shares held short 31.14M
  • Oct 15, 2025: Shares held short 30.17M
  • Oct 31, 2025: Shares held short 30.10M
  • Nov 14, 2025: Shares held short 29.18M
  • Nov 28, 2025: Shares held short 29.64M
  • Dec 15, 2025: Shares held short 29.86M
  • Dec 31, 2025: Shares held short 29.07M
  • Jan 15, 2026: Shares held short 29.74M
  • Jan 30, 2026: Shares held short 29.60M
  • Feb 13, 2026: Shares held short 29.61M
  • Feb 27, 2026: Shares held short 27.66M
  • Mar 13, 2026: Shares held short 28.03M
  • Mar 31, 2026: Shares held short 28.14M
  • Apr 15, 2026: Shares held short 27.97M
  • Apr 30, 2026: Shares held short 27.82M
  • May 15, 2026: Shares held short 28.11M
  • May 29, 2026: Shares held short 27.87M
  • Jun 15, 2026: Shares held short 25.64M
  • Jun 30, 2026: Shares held short 25.98M
  • Jul 15, 2026: Shares held short 23.89M
  • Jul 31, 2026: Shares held short 24.53M
  • Aug 14, 2026: Shares held short 24.00M
  • Aug 31, 2026: Shares held short 23.92M
  • Sep 15, 2026: Shares held short 22.85M
  • Sep 30, 2026: Shares held short 23.34M
  • Oct 15, 2026: Shares held short 12.45M

As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.

Short sales in daily trading61.1% of the shares in the last 14 sessions' reported trades were short sales.

In the last 14 sessions, 61.1% of the shares in the reported trades were short sales, against 57.3% in the 14 before.

Last 14 sessionsOct 30, 2026 – Nov 18, 2026
61.1%
The 14 beforeOct 12, 2026 – Oct 29, 2026
57.3%
Change
+3.8 pts
Short sales a dayon average, of 1.92M shares
1.17M
More than atof 3,656 US-listed companies, same days
85%
Median of alleight in ten from 34.4% to 63.7%
50.3%
  • Oct 12, 2026: Short sales 38.5%
  • Oct 13, 2026: Short sales 54.2%
  • Oct 14, 2026: Short sales 54.7%
  • Oct 15, 2026: Short sales 64%
  • Oct 16, 2026: Short sales 57.7%
  • Oct 19, 2026: Short sales 58.5%
  • Oct 20, 2026: Short sales 52.5%
  • Oct 21, 2026: Short sales 63.1%
  • Oct 22, 2026: Short sales 61.2%
  • Oct 23, 2026: Short sales 57.7%
  • Oct 26, 2026: Short sales 55.8%
  • Oct 27, 2026: Short sales 52.6%
  • Oct 28, 2026: Short sales 58.9%
  • Oct 29, 2026: Short sales 58.7%
  • Oct 30, 2026: Short sales 59.5%
  • Nov 2, 2026: Short sales 50.6%
  • Nov 3, 2026: Short sales 76.1%
  • Nov 4, 2026: Short sales 63.9%
  • Nov 5, 2026: Short sales 51%
  • Nov 6, 2026: Short sales 70.2%
  • Nov 9, 2026: Short sales 74.8%
  • Nov 10, 2026: Short sales 64.5%
  • Nov 11, 2026: Short sales 63.9%
  • Nov 12, 2026: Short sales 60.5%
  • Nov 13, 2026: Short sales 66.3%
  • Nov 16, 2026: Short sales 57.6%
  • Nov 17, 2026: Short sales 49.7%
  • Nov 18, 2026: Short sales 47.3%

This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.

What the insiders hold

The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.

941.7K Insiders' shares0.63% Of the company
  • Dennis M LanfearPresident & CEO
    Directly731.7K
  • Mats WahlstromDirector
    Directly30.0K
  • Ali J. SatvatDirector
    Directly30.0K
  • Rita A KarachunDirector
    Directly30.0K
  • Lee Nisley NewcomerDirector
    Directly30.0K
  • Michael Lee RyanDirector
    Directly30.0K
  • Jill O'Donnell-TormeyDirector
    Directly30.0K
  • Charles W. NewtonDirector
    Directly30.0K

A lower bound: it counts only the 8 officers and directors with a market trade since Nov 20, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.

The ETFs that hold it

Which of the 345 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.

11 ETFs holding it0.04% The largest weight (IWC)
  • IWCiShares Micro-Cap ETF
    Weight in the fund0.04%
  • IWNiShares Russell 2000 Value ETF
    Weight in the fund0.01%
  • VTWOVanguard Russell 2000 Index Fund
    Weight in the fund0.01%
  • IWMiShares Russell 2000 ETF
    Weight in the fund0.01%
  • SCHASchwab U.S. Small-Cap ETF
    Weight in the fund0.00%
  • IWOiShares Russell 2000 Growth ETF
    Weight in the fund0.00%
  • VXFVanguard Extended Market Index Fund
    Weight in the fund0.00%
  • SCHBSchwab U.S. Broad Market ETF
    Weight in the fund0.00%
  • VTIVanguard Total Stock Market Index Fund
    Weight in the fund0.00%
  • IWViShares Russell 3000 ETF
    Weight in the fund0.00%

11 of the 345 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.

Institutional investors by quarter

Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.

147 Managers, Q2 2026$99M Value of their positions
  • Q3 2025: Managers 114
  • Q4 2025: Managers 128
  • Q1 2026: Managers 159
  • Q2 2026: Managers 147

Institutional investors by quarter

The fund managers holding CHRS, quarter by quarter, from Q4 2014 to Q2 2025, 43 more quarters

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 12 quarters.

Q2 2026: 147 managers held 70.37M shares, worth $99M. During the quarter 11 opened a position, 23 closed one, 60 added and 39 trimmed.

The largest holders, Q2 2026

  • Timothy G. Youngquist 2020 Irrevocable Trust
    In the quarter+6.2%
  • BlackRock
    In the quarter+16%
  • Vanguard Capital Management
    In the quarter+9.1%
  • Geode Capital Management
    In the quarter+18%
  • Samsara Biocapital
    In the quarter
  • Kohlberg Kravis Roberts
    In the quarter
  • State Street
    In the quarter+2.4%
  • Two Sigma Investments
    In the quarter-1.9%
  • CM Management
    In the quarter
  • C WorldWide Group Holding A/S
    In the quarter

From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.

Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.

The full analysis

What do Coherus Oncology's filings show?

Who buys and sells is one part of Coherus Oncology's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about CHRS's shareholders

Didn't find what you were looking for?

Ask us
Have CHRS's insiders bought or sold?

From Jun 2, 2026 to Jun 9, 2026 Coherus Oncology's insiders reported no purchase or sale of shares on the market.

Which well-known managers hold CHRS?

4 of the managers we track held the shares on Sep 30, 2026. The largest position was Renaissance Technologies's, worth $1.1M.

Is every insider transaction a purchase or a sale?

No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.